Started Apr 6, 2017 0 Replies 0 Favorites
Hi !This is Rupjani, my son Anuran was diagnosed with DMD in 2010 when we are in Wisconsin . We were there from 2010 to 2013 , after that we returned to India . Once again , we are back in U.S. ,…Continue
Started this discussion. Last reply by Rupjani B Oct 15, 2014. 4 Replies 0 Favorites
I've just read Santhera FAQ family friendly version.It is written in question no 4 that:Currently, Santhera anticipates that the label sought will be restricted to patients who are not using…Continue
Started Nov 7, 2012 0 Replies 2 Favorites
Summit Corporation plc ('Summit' or 'the Company') REPEAT DOSING OF SMT C1100 FOR TREATMENT OF DUCHENNE MUSCULAR DYSTROPHY MEETS ENDPOINTS IN PHASE 1 CLINICAL TRIAL * New formulation delivers…Continue
Started this discussion. Last reply by Rupjani B Aug 14, 2012. 3 Replies 0 Favorites
I got an e.mail from Summit with an updated Q&A of SMT C 1100.These are the main two questions:. When could patient trials commenceIf the Phase I trial in healthy volunteers is successful, a…Continue
© 2023 Created by PPMD.
Powered by
Badges | Report an Issue | Privacy Policy | Terms of Service
Comment Wall
You need to be a member of PPMD Community to add comments!
Join PPMD Community